OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes
Hananeh Fonoudi, Mariam Jouni, Romina B. Cejas, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 1, pp. 38-50
Open Access | Times Cited: 15

Showing 15 citing articles:

Anthracycline Cardiotoxicity in Adult Cancer Patients
Massimiliano Camilli, Carlo M. Cipolla, Susan Dent, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 5, pp. 655-677
Open Access | Times Cited: 21

A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
Anjali Bisht, Dubey Avinash, Kantrol Kumar Sahu, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 11

Genetic factors in the pathogenesis of cardio-oncology
Yalong Qi, Yuhan Wei, Lixi Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Edaravone is a Therapeutic Candidate for Doxorubicin‐Induced Cardiomyopathy by Activating the Nrf2 Pathway
Naoki Yoshikawa, Naoto Hirata, Yuichiro Kurone, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access

Cancer-Therapy-Related Cardiac Dysfunction: Latest Advances in Prevention and Treatment
Carla Contaldi, Carmine D’Aniello, Domenico Panico, et al.
Life (2025) Vol. 15, Iss. 3, pp. 471-471
Open Access

Advances in humanoid organoid-based research on inter-organ communications during cardiac organogenesis and cardiovascular diseases
Baoqiang Ni, Lingqun Ye, Yan Zhang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

SNP’s use as a potential chemotoxicity stratification tool in breast cancer: from bench to clinic
Hebatallah Ahmed Mohamed Moustafa, Walaa A. El‐Dakroury, Alaa Ashraf, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access

Doxorubicin-Induced Cardiotoxicity and the Emerging Role of SGLT2 Inhibitors: From Glycemic Control to Cardio-Oncology
Iacob-Daniel Goje, Greta Ionela Barbulescu, Valentin Ordodi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 5, pp. 681-681
Open Access

Cardiovascular Toxicity in Cancer Therapy: Protecting the Heart while Combating Cancer
Amit Manhas, Dipti Tripathi, Dilip Thomas, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 9, pp. 953-971
Closed Access | Times Cited: 2

Research Progress on the Mechanism, Monitoring, and Prevention of Cardiac Injury Caused by Antineoplastic Drugs—Anthracyclines
Yuanyuan Chen, Wenwen Yang, Xiaoshan Cui, et al.
Biology (2024) Vol. 13, Iss. 9, pp. 689-689
Open Access | Times Cited: 2

Genetic and epigenetic bases of long-term adverse effects of childhood cancer therapy
Zhaoming Wang, Jinghui Zhang
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 2

Harnessing iPSCs to Dissect Causality in Anthracycline-Induced Cardiotoxicity
Dilip Thomas, Amit Manhas, Nazish Sayed
JACC CardioOncology (2024) Vol. 6, Iss. 1, pp. 51-54
Open Access | Times Cited: 1

Evolving therapeutics and ensuing cardiotoxicities in triple-negative breast cancer
Chongyu Wang, Pinchao Fan, Qingqing Wang
Cancer Treatment Reviews (2024) Vol. 130, pp. 102819-102819
Open Access | Times Cited: 1

Straight to the heart: Protecting the patient’s heart during chemotherapy
Rachel Conyers, David A. Elliott
Cell stem cell (2024) Vol. 31, Iss. 12, pp. 1715-1716
Closed Access

Page 1

Scroll to top